देश: कनाडा
भाषा: अंग्रेज़ी
स्रोत: Health Canada
IBUPROFEN; DIPHENHYDRAMINE HYDROCHLORIDE
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
M01AE51
IBUPROFEN, COMBINATIONS
200MG; 25MG
CAPSULE
IBUPROFEN 200MG; DIPHENHYDRAMINE HYDROCHLORIDE 25MG
ORAL
15G/50G
OTC
OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS
Active ingredient group (AIG) number: 0252788001; AHFS:
APPROVED
2013-02-14
_ _ _GlaxoSmithKline Consumer Healthcare Inc. _ _Page 1 of 44_ PRODUCT MONOGRAPH _ _ ADVIL COLD, COUGH & FLU NIGHTTIME Ibuprofen 200 mg and Diphenhydramine Hydrochloride 25 mg Capsules Analgesic/Antipyretic and Antihistamine/Antitussive GlaxoSmithKline Consumer Healthcare Inc. 7333 Mississauga Road Mississauga, Ontario L5N 6L4 Date of Preparation: January 29, 2013 Date of Revision: May 5, 2020 Submission Control No: 237365 _ _ _GlaxoSmithKline Consumer Healthcare Inc. _ _Page 2 of 44_ TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION .........................................................3 SUMMARY PRODUCT INFORMATION ........................................................................3 INDICATIONS AND CLINICAL USE ..............................................................................3 CONTRAINDICATIONS ...................................................................................................4 WARNINGS AND PRECAUTIONS ..................................................................................5 ADVERSE REACTIONS ..................................................................................................12 DRUG INTERACTIONS ..................................................................................................19 DOSAGE AND ADMINISTRATION ..............................................................................23 OVERDOSAGE ................................................................................................................23 ACTION AND CLINICAL PHARMACOLOGY ............................................................25 STORAGE AND STABILITY ..........................................................................................28 SPECIAL HANDLING INSTRUCTIONS .......................................................................28 DOSAGE FORMS, COMPOSITION AND PACKAGING .............................................28 PART II: SCIENTIFIC INFORMATION ...................................................................29 PHARMACEUTICAL INFORMATION पूरा दस्तावेज़ पढ़ें